Linkage analysis of a candidate region in Scandinavian sib pairs with multiple sclerosis reveals linkage to chromosome 17q

Genes and Immunity

Volumn 1, Issue 7, 2000, Pages 456-459

  Larsen, F ^a   Oturai, A ^a   Ryder, L P ^a   Madsen, H O ^a   Hillert, J ^b   Fredrikson, S ^b   Sandberg Wollheim, M ^c   Laaksonen, M ^g   Flinstad Harbo, H ^d   Sawcer, S ^e   Fugger, L ^f   Sorensen, P S ^a   Svejgaard, A ^a  

^a Rigshospitalet   (Denmark)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^f AARHUS UNIVERSITY HOSPITAL   (Denmark)

^g NONE

Author keywords

Candidate regions; Genetic susceptibility; Linkage analysis; Multiple sclerosis

Indexed keywords

HLA DR2 ANTIGEN; MICROSATELLITE DNA;

ARTICLE; CHROMOSOME 17; FEMALE; GENETIC LINKAGE; GENETICS; HETEROZYGOTE; HUMAN; IMMUNOLOGY; MALE; MULTIPLE SCLEROSIS; SCANDINAVIA;

CHROMOSOMES, HUMAN, PAIR 17; FEMALE; HETEROZYGOTE; HLA-DR2 ANTIGEN; HUMANS; LINKAGE (GENETICS); MALE; MICROSATELLITE REPEATS; MULTIPLE SCLEROSIS; SCANDINAVIA;

EID: 0034303287     PISSN: 14664879     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gene.6363705     Document Type: Article

References (26)

1. Sadovnick AD, Armstrong H, Rice GP et al. A population-based study of multiple sclerosis in twins: update. Ann Neurol 1993; 33: 281-285.
2. Mumford CJ, Wood NW, Kellar-Wood H, Thorpe JW, Miller DH, Compston DA. The British Isles survey of multiple sclerosis in twins. Neurology 1994; 44: 11-15.
3. Ebers GC, Sadovnick AD, Risch NJ. A genetic basis for familial aggregation in multiple sclerosis. Nature 1995; 377: 150-151.
4. Sadovnick AD, Ebers GC, Dyment DA, Risch NJ. Evidence for genetic basis of multiple sclerosis. Lancet 1996; 347: 1728-1730.
5. Robertson NP, O'Riordan JI, Chataway J et al. Offspring recurrence rates and clinical characteristics of conjugal multiple sclerosis. Lancet 1997; 349: 1587-1590.
6. Sawcer S, Jones HB, Feakes R et al. A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22. Nature Genet 1996; 13: 464-468.
7. Haines JL, Ter-Minassian M, Bazyk A et al. A complete genomic screen for multiple sclerosis underscores a role for the major histocompatability complex. Nature Genet 1996; 13: 469-471.
8. Ebers GC, Kukay K, Bulman DE et al. A full genome search in multiple sclerosis. Nature Genet 1996; 13: 472-476.
9. Kuokkanen S, Gschwend M, Rioux JD et al. Genomewide scan of multiple sclerosis in Finnish multiplex families. Am J Hum Genet 1997; 61: 1379-1387.
10. Coraddu F, Sawcer S, Feakes R et al. HLA typing in the United Kingdom multiple sclerosis genome screen. Neurogenetics 1998; 2: 24-33.
11. Haines JL, Terwedow HA, Burgess K et al. Linkage of the MHC to familial multiple sclerosis suggests genetic heterogeneity. Hum Mol Genet 1998; 7: 1229-1234.
12. Marrosu MG, Murru MR, Costa G, Murru R, Muntoni F, Cucca F. DRB1-DQA1-DQB1 loci and multiple sclerosis predisposition in the Sardinian population. Hum Mol Genet 1998; 7: 1235-1237.
13. Oturai A, Larsen F, Ryder LP et al. Linkage and association analysis of susceptibility regions on chromosomes 5 and 6 in 106 Scandinavian sibling pair families with multiple sclerosis. Ann Neurol 1999; 46: 612-616.
14. Kurtzke JF. Epidemiologic contributions to multiple sclerosis: an overview. Neurology 1980; 30: 61-79.
15. Poser CM, Paty DW, Scheinberg L et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13: 227-231.
16. Kimura A, Sasazuki T. Eleventh International Histocompatibility Workshop reference protocol for the HLA DNA-typing technique. In: Tsuji K, Aizawa M, Sasazuki T (eds). HLA 1991. Oxford, 1992, pp 397-419.
17. Holmans P, Clayton D. Efficiency of typing unaffected relatives in an affected-sib-pair linkage study with single-locus and multiple tightly linked markers. Am J Med Genet 1995; 57: 1221-1232.
18. Kruglyak L, Lander ES. Complete multipoint sib-pair analysis of qualitative and quantitative traits. Am J Med Genet 1995; 57: 439-454.
19. Roberts SB, MacLean CJ, Neale MC, Eaves LJ, Kendler KS. Replication of linkage studies of complex traits: an examination of variation in location estimates. Am J Hum Genet 1999; 65: 876-884.
20. Fontaine B, Cournu I, Babron M-C et al. Chromosome 17q22-q24 and multiple sclerosis genetic susceptibility. Genes Immun 1999; 1: 149-150.
21. Robertson NP, Clayton D, Fraser M, Deans J, Compston DA. Clinical concordance in sibling pairs with multiple sclerosis. Neurology 1996; 47: 347-352.
22. Sorensen TL, Tani M, Jensen J et al. Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. J Clin Invest 1999; 103: 807-815.
23. Balashov KE, Rottman JB, Weiner HL, Hancock WW. CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions. Proc Natl Acad Sci USA 1999; 96: 6873-6878.
24. Sellebjerg F, Madsen HO, Jensen CV, Jensen J, Garred P. CCR5 delta32, matrix metalloproteinase-9 and disease activity in multiple sclerosis. J Neuroimmunol 2000; 102: 98-106.
25. Nagra RM, Becher B, Tourtellotte WW et al. Immunohistochemical and genetic evidence of myeloperoxidase involvement in multiple sclerosis. J Neuroimmunol 1997; 78: 97-107.
26. Chataway J, Sawcer S, Feakes R et al. A screen of candidates from peaks of linkage: evidence for the involvement of myeloperoxidase in multiple sclerosis. J Neuroimmunol 1999; 98: 208-213.